The platform discovered, not created.

Professor Robert Gourdie is the founder of The Tiny Cargo Company. A biomedical scientist with over three decades of peer‑reviewed research, he is the Heywood Fralin Endowed Professor at the Fralin Biomedical Research Institute at Virginia Tech. He is a recipient of the US National Institute of Health Outstanding Investigator Award, an elected fellow of the American Institute for Medical and Biological Engineering and the American Heart Association, and an elected senior member of the National Academy of Inventors. With more than 200 peer‑reviewed publications, an h‑index of 71, and over 50 granted patents he brings an exceptional record of scientific achievement to the scientific vision behind the Tiny Cargo platform, along with a strong track record of translating discoveries from the laboratory to commercial application. Robert holds a Ph.D. from the University of Canterbury in New Zealand and completed his postdoctoral fellowship at University College London in the United Kingdom.

Spencer Marsh is Chief Scientific Officer of XO-Cargo™ and the scientist who achieved the first successful isolation of milk exosomes from bovine milk in 2020 — the founding discovery of the XO-Cargo™ platform. Under Spencer’s scientific leadership, XO-Cargo™ has developed the world’s first industrially-scaled milk exosome facility, achieving kilogram-scale production of highly purified exosomes to a fixed cGMP-aligned commercial specification. Spencer oversees all scientific operations, analytical standards, and the ongoing development of the XO-Cargo™ ingredient platform.

Alan Gourdie is Chairman and Chief Executive Officer of Tiny Cargo.  With more than 30 years of executive leadership across multinational corporations and high-growth start-ups, he has founded and built companies that have reshaped the pharmaceutical, consumer goods, cosmetics, technology, and life sciences sectors, and has guided major public and private enterprises as Chair and Director — including his Board leadership at The Tiny Cargo Company. At Tiny Cargo, Alan sets the overall strategic direction of the company, on a mission to bring the world’s first industrially-scaled milk exosome platform to the global pharmaceutical and cosmetics industries. He is responsible for shaping the commercial strategy, supply infrastructure, and global market development that will turn breakthrough science into a transformative therapeutic technology. Together with his team at Tiny Cargo his vision is to redefine how the world’s medicines are delivered. He holds an MSc.

Sherri Cook is a financial executive with more than two decades of leadership experience across biomedical research, academic health sciences and complex financial operations. She currently holds senior leadership roles at Virginia Tech, overseeing financial strategy, research administration and enterprise operations for a large NIH-funded research institute and the health sciences ecosystem. At XO-Cargo™, Sherri provides strategic financial leadership to support growth, strengthen operational infrastructure and position the organisation for long-term success.

W. Heywood Fralin is Co-Chairman of Retirement Unlimited, Inc. and a longstanding leader in advancing biomedical research, higher education and innovation throughout Virginia. He has served on the Boards of Visitors at Virginia Tech and the University of Virginia — where he also served as Rector — and as Chairman of the State Council of Higher Education for Virginia. His career has been shaped by a deep commitment to strengthening Virginia’s scientific and economic future, most notably through his advocacy and philanthropic support of the Fralin Biomedical Research Institute at Virginia Tech. At XO-Cargo™, Heywood brings decades of experience connecting scientific research with commercial and economic development across the Virginia region.

Richard Warburg brings to XO-Cargo™ four decades of experience guiding life-sciences companies from early-stage science through commercial scale. A molecular biologist turned patent attorney, Richard combines deep scientific fluency with the governance, IP and transactional expertise required to bring platform biotechnologies to market. He is a board director of several life-sciences companies, including eLux Medical, which is developing gold nanoshell (AuroShell™) technology for medical applications including fat removal, and Rose Pharma, a GLP-1 drug development company. At XO-Cargo™, Richard supports the Board in overseeing strategy, intellectual property and the commercial development of the world’s first industrially-scaled milk exosome platform.

Add team member biography here.

Alan Dogan is a physician and biomedical engineer who earned his MD from the Virginia Tech Carilion School of Medicine and his BS and MS degrees in Biomedical Engineering from Case Western Reserve University. His work centers on translational healthcare technologies, clinical research, and medical device innovation, with experience in ophthalmic imaging, respiratory monitoring, and drug delivery. He has contributed to early-stage clinical studies, device development, and interdisciplinary collaborations aimed at bringing practical healthcare innovations closer to patients.

Raleigh Keenan is the Manufacturing Technician at XO-Cargo™, supporting the industrial-scale production and processing of milk-derived exosomes for the company’s therapeutic platform. She contributes to cleanroom manufacturing, logistics coordination, and cGMP-aligned operations. Raleigh holds a background in bioengineering with experience in biomaterials, tissue engineering, and wet lab research. She previously served as Laboratory Manager and a Graduate Research Assistant at Clemson University’s Biocompatibility and Tissue Regeneration Laboratory.

Alisha Clark is a strategic brand and communications specialist with a decade of experience across luxury fashion, beauty and purpose-led businesses in the United Kingdom and New Zealand. Her career spans some of the most respected names in luxury consumer brands — from Tom Ford and NET-A-PORTER in London, to senior communications leadership at a leading luxury skincare brand. She founded Alisha Wheeler Consulting in 2021, advising values-aligned businesses on brand strategy and communications. At XO-Cargo™, Alisha leads marketing and communications — bringing the rigour of luxury brand building to the commercialisation of a genuinely new ingredient category.

Professor Richard Archer is an Emeritus Professor of Food Technology at Massey University, New Zealand, and one of the world’s leading authorities on dairy bioprocessing. He brings four decades of experience spanning senior technical management in the New Zealand dairy industry — including the isolation of milk components for pharmaceutical and cosmetic use — and research and departmental leadership in the university setting. His primary expertise is bioprocess engineering, with core experience in milk and whey processing. He now consults and advises in this field.

Vishal Suri is a technology entrepreneur and IT executive. He was the founder and CEO of TSPi, a Virginia-based digital transformation and IT consulting company. Under his leadership, TSPi grew into a respected provider of cloud, data, and agile software solutions, earning multiple “Top Workplace” recognitions from The Washington Post. In 2024, TSPi was acquired by Abt Global, a Maryland-based research and consulting firm, to expand its digital and modernization capabilities. Before founding TSPi, Suri worked at FastTide on web acceleration technologies and began his career at PSINet, where he contributed to large-scale web hosting initiatives, including support for NASA-related projects tied to Senator John Glenn’s 1998 space flight. He has a varied academic background which includes a Bachelor of Science in Information Systems, and Diplomas in Hotel Management and Advanced Culinary Arts.